Study of capsule endoscopy delivery at scale through enhanced <scp>artificial intelligence‐enabled</scp> analysis (the CESCAIL study)

Abstract

This standard diagnostic accuracy study carries no additional risk to patients as it does not affect the standard care pathway, and hence patient care remains unaffected.